Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Assets: 2019-2025

Historic Return on Assets for Bicycle Therapeutics (BCYC) over the last 6 years, with Sep 2025 value amounting to -0.32%.

  • Bicycle Therapeutics' Return on Assets fell 16.00% to -0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.32%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of -0.23% for FY2024, which is 13.00% up from last year.
  • As of Q3 2025, Bicycle Therapeutics' Return on Assets stood at -0.32%, which was down 11.11% from -0.29% recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Return on Assets high stood at -0.16% for Q3 2024, and its period low was -0.33% during Q2 2023.
  • Over the past 3 years, Bicycle Therapeutics' median Return on Assets value was -0.29% (recorded in 2023), while the average stood at -0.27%.
  • Its Return on Assets has fluctuated over the past 5 years, first increased by 15bps in 2024, then dropped by 16bps in 2025.
  • Bicycle Therapeutics' Return on Assets (Quarterly) stood at -0.18% in 2021, then decreased by 11bps to -0.29% in 2022, then remained steady at -0.29% in 2023, then rose by 11bps to -0.18% in 2024, then fell by 16bps to -0.32% in 2025.
  • Its Return on Assets was -0.32% in Q3 2025, compared to -0.29% in Q2 2025 and -0.23% in Q1 2025.